APLTApplied Therapeutics Inc

$0.108
$0.00
(0.00%)
Pre-Market
Updated: 12:00 AM EST·Prev Close $0.108
Reported EarningsNov 13
Mkt Cap$14.86M

About

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
35

Frequently Asked Questions

What is Market Cap of Applied Therapeutics Inc?
What is the 52-week high for Applied Therapeutics Inc?
What is the 52-week low for Applied Therapeutics Inc?
What is Applied Therapeutics Inc stock price today?
What was Applied Therapeutics Inc stock price yesterday?
What is the PE ratio of Applied Therapeutics Inc?
What is the Price-to-Book ratio of Applied Therapeutics Inc?
What is the 50-day moving average of Applied Therapeutics Inc?
How many employees does Applied Therapeutics Inc have?

Advertisement|Remove ads.